Australian Measles Control Campaign

Last updated

The Australian Measles Control Campaign was initiated in August 1998 as part of the World Health Organization's global measles eradication program, and in response to major epidemics in Australia throughout 1994/95, together with a report predicting another impending measles epidemic in Australia. The campaign vaccinated 1.78 million children, making it the largest national vaccination campaign conducted in Australia since the introduction of poliomyelitis vaccination in 1956.[ citation needed ]

Contents

The campaign was promoted using the slogan "Let's Work Together to Beat Measles". [1]

The campaign

Following the World Health Organization's adoption of a 2010 target date for Global Measles eradication and the notation that a single dose vaccination strategy was ineffective, the Federal Health Department began investigating the options for a measles elimination campaign in Australia. In 1996 and 1997, serosurveys were conducted in South Australia and New South Wales to assess the current levels of measles immunity. Results indicated that there were "probably enough susceptible children in the South Australian population to support a measles epidemic". In November 1997, a workshop of experts was formed to discuss the logistical, funding and surveillance issues of a potential measles elimination campaign. The group concluded that the second dose of MMR should be brought forward from 12 years to 4 years (in line with WHO recommendations), and that a school-based campaign be implemented. [1] Three groups would be targeted for vaccination:[ citation needed ]

Objectives

Statistics

Measles morbidity in Australia, 1991-2009 Graphs measles Australia 1991-2009.jpg
Measles morbidity in Australia, 1991–2009

Results

Related Research Articles

<span class="mw-page-title-main">Vaccination</span> Administration of a vaccine to protect against disease

Vaccination is the administration of a vaccine to help the immune system develop immunity from a disease. Vaccines contain a microorganism or virus in a weakened, live or killed state, or proteins or toxins from the organism. In stimulating the body's adaptive immunity, they help prevent sickness from an infectious disease. When a sufficiently large percentage of a population has been vaccinated, herd immunity results. Herd immunity protects those who may be immunocompromised and cannot get a vaccine because even a weakened version would harm them. The effectiveness of vaccination has been widely studied and verified. Vaccination is the most effective method of preventing infectious diseases; widespread immunity due to vaccination is largely responsible for the worldwide eradication of smallpox and the elimination of diseases such as polio and tetanus from much of the world. However, some diseases, such as measles outbreaks in America, have seen rising cases due to relatively low vaccination rates in the 2010s – attributed, in part, to vaccine hesitancy. According to the World Health Organization (WHO), vaccination prevents 3.5–5 million deaths per year.

<span class="mw-page-title-main">Measles</span> Viral disease affecting humans

Measles is a highly contagious infectious disease caused by measles virus. Symptoms usually develop 10–12 days after exposure to an infected person and last 7–10 days. Initial symptoms typically include fever, often greater than 40 °C (104 °F), cough, runny nose, and inflamed eyes. Small white spots known as Koplik's spots may form inside the mouth two or three days after the start of symptoms. A red, flat rash which usually starts on the face and then spreads to the rest of the body typically begins three to five days after the start of symptoms. Common complications include diarrhea, middle ear infection (7%), and pneumonia (6%). These occur in part due to measles-induced immunosuppression. Less commonly seizures, blindness, or inflammation of the brain may occur. Other names include morbilli, rubeola, red measles, and English measles. Both rubella, also known as German measles, and roseola are different diseases caused by unrelated viruses.

<span class="mw-page-title-main">Mumps</span> Human disease caused by paramyxovirus

Mumps is a viral disease caused by the mumps virus. Initial symptoms are non-specific and include fever, headache, malaise, muscle pain, and loss of appetite. These symptoms are usually followed by painful swelling of the parotid glands, called parotitis, which is the most common symptom of infection. Symptoms typically occur 16 to 18 days after exposure to the virus and resolve within two weeks. About one third of infections are asymptomatic.

<span class="mw-page-title-main">MMR vaccine</span> Any of several combined vaccines against measles, mumps, and rubella

The MMR vaccine is a vaccine against measles, mumps, and rubella, abbreviated as MMR. The first dose is generally given to children around 9 months to 15 months of age, with a second dose at 15 months to 6 years of age, with at least four weeks between the doses. After two doses, 97% of people are protected against measles, 88% against mumps, and at least 97% against rubella. The vaccine is also recommended for those who do not have evidence of immunity, those with well-controlled HIV/AIDS, and within 72 hours of exposure to measles among those who are incompletely immunized. It is given by injection.

<span class="mw-page-title-main">Herd immunity</span> Concept in epidemiology

Herd immunity is a form of indirect protection that applies only to contagious diseases. It occurs when a sufficient percentage of a population has become immune to an infection, whether through previous infections or vaccination, thereby reducing the likelihood of infection for individuals who lack immunity.

<span class="mw-page-title-main">Rubella</span> Human viral disease

Rubella, also known as German measles or three-day measles, is an infection caused by the rubella virus. This disease is often mild, with half of people not realizing that they are infected. A rash may start around two weeks after exposure and last for three days. It usually starts on the face and spreads to the rest of the body. The rash is sometimes itchy and is not as bright as that of measles. Swollen lymph nodes are common and may last a few weeks. A fever, sore throat, and fatigue may also occur. Joint pain is common in adults. Complications may include bleeding problems, testicular swelling, encephalitis, and inflammation of nerves. Infection during early pregnancy may result in a miscarriage or a child born with congenital rubella syndrome (CRS). Symptoms of CRS manifest as problems with the eyes such as cataracts, deafness, as well as affecting the heart and brain. Problems are rare after the 20th week of pregnancy.

Vaccine hesitancy is a delay in acceptance, or downright refusal, of vaccines despite the availability of vaccine services. The term covers outright refusals to vaccinate, delaying vaccines, accepting vaccines but remaining uncertain about their use, or using certain vaccines but not others. The scientific consensus that vaccines are generally safe and effective is overwhelming. Vaccine hesitancy often results in disease outbreaks and deaths from vaccine-preventable diseases. Therefore, the World Health Organization characterizes vaccine hesitancy as one of the top ten global health threats.

The MMRV vaccine combines the attenuated virus MMR vaccine with the addition of the chickenpox vaccine or varicella vaccine. The MMRV vaccine is typically given to children between one and two years of age.

<span class="mw-page-title-main">Mumps vaccine</span> Vaccine which prevents mumps

Mumps vaccines are vaccines which prevent mumps. When given to a majority of the population they decrease complications at the population level. Effectiveness when 90% of a population is vaccinated is estimated at 85%. Two doses are required for long term prevention. The initial dose is recommended between 12 and 18 months of age. The second dose is then typically given between two years and six years of age. Usage after exposure in those not already immune may be useful.

Claims of a link between the MMR vaccine and autism have been extensively investigated and found to be false. The link was first suggested in the early 1990s and came to public notice largely as a result of the 1998 Lancet MMR autism fraud, characterised as "perhaps the most damaging medical hoax of the last 100 years". The fraudulent research paper authored by Andrew Wakefield and published in The Lancet claimed to link the vaccine to colitis and autism spectrum disorders. The paper was retracted in 2010 but is still cited by anti-vaccinationists.

A vaccination policy is a health policy adopted in order to prevent the spread of infectious disease. These policies are generally put into place by State or local governments, but may also be set by private facilities, such as workplaces or schools. Many policies have been developed and implemented since vaccines were first made widely available.

<span class="mw-page-title-main">Eradication of infectious diseases</span> Complete extermination of disease causing agent effectively to reduce its incidence to zero

Eradication is the reduction of an infectious disease's prevalence in the global host population to zero.

<span class="mw-page-title-main">Measles vaccine</span> Vaccine used to prevent measles

Measles vaccine protects against becoming infected with measles. Nearly all of those who do not develop immunity after a single dose develop it after a second dose. When rate of vaccination within a population is greater than 92%, outbreaks of measles typically no longer occur; however, they may occur again if the rate of vaccination decrease. The vaccine's effectiveness lasts many years. It is unclear if it becomes less effective over time. The vaccine may also protect against measles if given within a couple of days after exposure to measles.

<span class="mw-page-title-main">Rubella vaccine</span> Vaccine used to prevent rubella

Rubella vaccine is a vaccine used to prevent rubella. Effectiveness begins about two weeks after a single dose and around 95% of people become immune. Countries with high rates of immunization no longer see cases of rubella or congenital rubella syndrome. When there is a low level of childhood immunization in a population it is possible for rates of congenital rubella to increase as more women make it to child-bearing age without either vaccination or exposure to the disease. Therefore, it is important for more than 80% of people to be vaccinated. By introducing rubella containing vaccines, rubella has been eradicated in 81 nations, as of mid-2020.

The 2012–2013 Swansea measles epidemic began in November 2012 and was declared over on 3 July 2013. There were a total of 1,219 measles notifications in Swansea, Neath Port Talbot, Bridgend, Carmarthenshire, Ceredigion, Pembrokeshire and Powys, with 1,455 measles notifications for the whole of Wales, 664 of which were in Swansea alone. A total of 88 people were hospitalised for measles infection during the epidemic. One death was reported: a 25-year-old man with giant cell pneumonia brought on by measles infection died on 18 April 2013. The cost associated with treating the sick and controlling the outbreak exceeded £470,000 ($701,898).

<span class="mw-page-title-main">Epidemiology of measles</span>

Measles is extremely contagious, but surviving the infection results in lifelong immunity, so its continued circulation in a community depends on the generation of susceptible hosts by birth of children. In communities which generate insufficient new hosts the disease will die out. This concept was first recognized by Bartlett in 1957, who referred to the minimum number supporting measles as the critical community size (CCS). Analysis of outbreaks in island communities suggested that the CCS for measles is c. 250,000.

<span class="mw-page-title-main">Measles resurgence in the United States</span> Sharp increase in measles cases between 2010 and 2019

Measles was declared eliminated from the United States in 2000 by the World Health Organization due to the success of vaccination efforts. However, it continues to be reintroduced by international travelers, and in recent years, anti-vaccination sentiment has allowed for the reemergence of measles outbreaks.

<span class="mw-page-title-main">2019–2020 New Zealand measles outbreak</span> Measles epidemic affecting New Zealand

The 2019–2020 New Zealand measles outbreak was an epidemic that affected New Zealand, primarily the Auckland region. The outbreak was the worst epidemic in New Zealand since an influenza epidemic in 1999, and is the worst measles epidemic since 1938.

<span class="mw-page-title-main">Vaccination policy of the United States</span> Overview of the vaccination policy in the United States of America

Vaccination policy in the United States is the subset of U.S. health policy that deals with immunization against infectious disease. It is decided at various levels of the government, including the individual states. This policy has been developed over the approximately two centuries since the invention of vaccination with the purpose of eradicating disease from the U.S. population, or creating a herd immunity. Policies intended to encourage vaccination impact numerous areas of law, including regulation of vaccine safety, funding of vaccination programs, vaccine mandates, adverse event reporting requirements, and compensation for injuries asserted to be associated with vaccination.

Misinformation related to immunization circulates in mass media and social media. Intentional spreading of false information and conspiracy theories have also been propagated by the general public and celebrities. Misinformation related to vaccination fuels vaccine hesitancy and thereby results in disease outbreaks. Although opposition to vaccination has existed for centuries, the internet and social media have recently facilitated the spread of vaccine-related misinformation. Unsubstantiated safety concerns related to vaccines are often presented on the internet as scientific information.

References

  1. 1 2 3 4 5 6 7 8 9 Let's Work Together to Beat Measles: A Report on Australia's Measles Control Campaign (PDF), Canberra: Commonwealth of Australia, 2000 [2000], ISBN   0-642-44682-2, archived from the original (PDF) on 2007-08-31 (Available via Internet Archive of Australia Department of Health webpage)
  2. 1 2 Gilbert, GL; Escott RG; Gidding HF; Turnbull FM; Heath TC; McIntyre PB; Burgess MA. (October 2001). "Impact of the Australian Measles Control Campaign on immunity to measles and rubella". Epidemiology and Infection. 127 (2): 297–303. doi:10.1017/s0950268801005830. PMC   2869749 . PMID   11693507.
  3. "National Notifiable Diseases Surveillance System". Australian Government, Department of Health and Ageing. Australian Government. Retrieved 7 May 2010.
  4. Cooper, Dani (11 February 2009). "Australia declared measles free". Australian Broadcasting Corporation. Retrieved 16 May 2010.